h.yilmaz
Submits third-party assay reports on material purchased directly. Based in Córdoba.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.27%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042221 | SS-31 (Elamipretide) | TFC | TFC-2607-R9099 | PeptideMeter | 2026-Q3 | 99.46 | 4.55 | 101.1 | Buyer-sourced | 0 | PASS |
| AX-2026-043498 | MOTS-c | QST | QST-2511-H5351 | Kestrel | 2026-Q2 | 98.36 | 5.08 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042974 | MK-677 (Ibutamoren mesylate) | MKM | MKM-2509-T3949 | Medutest | 2026-Q1 | 99.31 | 4.15 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-018459 | Tirzepatide | WWB | WWB-2506-T2732 | PeptideMeter | 2025-Q4 | 99.10 | 3.44 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019559 | TB-500 | TFC | TFC-2503-L9791 | Janoshik | 2025-Q3 | 99.33 | 5.72 | 96.6 | Buyer-sourced | 0 | PASS |
| AX-2025-018822 | NAD+ | FGP | FGP-2502-E8063 | Janoshik | 2025-Q3 | 99.71 | 10.32 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019841 | Semaglutide | Homopeptide | HOMO-2506-M5731 | Janoshik | 2025-Q3 | 97.93 | 6.02 | 91.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019398 | CJC-1295 (no DAC) | HYB | HYB-2504-N7248 | Nordanalyt | 2025-Q3 | 99.27 | 4.17 | 106.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004207 | Survodutide | WWB | WWB-2408-T3710 | Janoshik | 2024-Q4 | 98.86 | 3.21 | 95.9 | Buyer-sourced | 0 | PASS |